Drug Pipeline

Avapritinib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
5
Recruiting
4
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 2
2
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06748001 Avapritinib Rollover Study Mastocytosis, Systemic Recruiting
Phase 2
NCT04116541 A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular… Malignant Solid Tumor Recruiting
NCT04771520 Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or… Anatomic Stage IV Breast Cancer AJCC v8 Recruiting
Phase 1
NCT06327685 Avapritinib With Decitabine in Patients With SM-AHN Systemic Mastocytosis With an Associated Hematologic Neoplasm Recruiting
Not specified
NCT07255638 A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in… Indolent Systemic Mastocytosis Recruiting
Sponsors Running Avapritinib Trials
Blueprint Medicines Corporation (2) Centre Leon Berard (1) M.D. Anderson Cancer Center (1) H. Lee Moffitt Cancer Center and Research Institute (1)
Disease Areas
Lung Cancer (1) Breast Cancer (1) Colorectal Cancer (1) Melanoma (1) Sarcoma (1)
Get alerts when Avapritinib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free